Conformational analysis of 2-(carboxycyclopropyl)glycine agonists of glutamate receptors in aqueous solution using a combination of NMR and molecular modelling experiments and charge calculations

Abstract

Two classes of glutamate receptors [metabotropic (group-II) and ionotropic (NMDA) subclasses] are characterized by the binding of α-(carboxycyclopropyl)glycine (CCG) isomers, (2S,3S,4S)-CCG (L-CCG-I) and (2S,3R,4S)-CCG (L-CCG-IV) which contain an embedded L-glutamate moiety in a partially restricted conformation [relative to the C(3)–C(4) bond]. The spatial orientation of the perceived functional groups have been elucidated by a conformational analysis in aqueous solution of L-CCG-I and L-CCG-IV using a combination of NMR experimental results, theoretical simulation of NMR spectra, mechanics and dynamics calculations. It was of interest to compare the charge distributions resulting from a number of quantum calculations on the cyclopropane ring. One important conclusion of the study is that the best theoretical model is the MD in solvent. This study shows clearly the preferred ‘t-A’ and ‘g⁺-B’ conformations of the C(3) aminocarboxymethyl side chain for L-CCG-I and L-CCG-IV, respectively. Weak pH-dependent effects on the structure of the principal L-CCG-I and L-CCG-IV conformers have been established in aqueous solution. The conformations may be grouped by the two backbone torsion angles, χ₁ [α-CO₂^––C(2)–C(3)–C(4)] and χ₂ [⁺NC(2)–C(3)–C(4)–γ-CO₂^–] and by the two characteristic distances between the potentially active functional groups, α-N⁺–γ-CO₂^– (d₁) and α-CO₂^––γ-CO₂^– (d₂). The conformational preferences in solution of L-CCG-I and L-CCG-IV are discussed in the light of the physical features known for specific metabotropic (ACPD) and specific ionotropic (NMDA) agonists, respectively.

References

1. J. C. Watkins, P. Krogsgaard-Larsen and T. Honoré, Trends Pharmacol. Sci., 1990, 11, 25.
2. S. Nakanishi, Science, 1992, 258, 597.
3. T. V. P. Bliss and G. L. Collingridge, Nature (London), 1993, 361, 31.
4. D. T. Monoghan, R. J. Bridges and C. W. Cotman, Ann. Rev. Pharmacol. Toxicol., 1989, 29, 365.
5. R. H. Evans and J. C. Watkins, Ann. Rev. Pharmacol. Toxicol., 1981, 21, 165.
6. B. Sommer and P. H. Seeburg, Trends Pharmacol. Sci., 1992, 13, 291.
7. D. D. Schoepp and P. J. Conn, Trends Pharmacol. Sci., 1993, 14, 13.
8. J. P. Pin and R. Duvoisin, Neuropharmacology, 1995, 34, 1.
9. T. Abe, H. Sugihara, H. Nawa, H. Shigemoto, N. Mizuno and S. Nakanishi, J. Biol. Chem., 1992, 267, 13 361.
10. Y. Tanabe, A. Nomura, M. Masu, R. Shigemoto, N. Mizuno and S. Nakanishi, J. Neurosci., 1993, 13, 1372.
11. J. Davies, R. H. Evans, A. A. Francis, A. W. Jones, D. A. S. Smith and J. C. Watkins, Neurochem. Res., 1982, 7, 1119.
12. R. Chamberlin and R. Bridges, Conformationally constrained acidic amino acids as probes of Glutamate receptors and transporters, Raven Press, New York, 1993.
13. Y. Ohfune and H. Shinozaki, L-2-(Carboxycyclopropyl)glycines. Conformationally constrained L-glutamate analogues, Raven Press, New York, 1993.
14. M. Ishida, T. Saitoh and H. Shinozaki, Neurosci. Lett., 1993, 160, 156.
15. N. Morelle, J. Gharbi-Benarous, F. Acher, G. Valle, M. Crisma, C. Toniolo, R. Azerad and J.-P. Girault, J. Chem. Soc., Perkin Trans. 2, 1993, 525.
16. V. Larue, J. Gharbi-Benarous, F. Acher, G. Valle, M. Crisma, C. Toniolo, R. Azerad and J.-P. Girault, J. Chem. Soc., Perkin Trans. 2, 1995, 1111.
17. K. Shimamoto, M. Ishida, H. Shinozaki and Y. Ohfune, J. Org. Chem., 1991, 56, 4167.
18. G. Costantino, B. Natalini, R. Pellicciari, F. Moroni and G. Lombardi, Bioorg. Med. Chem., 1993, 4, 259.
19. E. L. Eliel, N. L. Allinger, S. J. Angyal and G. A. Morrison, Conformational Analysis, Wiley, New York, 1965.
20. O. Bastiansen and A. de Meijere, Acta Chem. Scand., 1966, 20, 516.
21. O. Bastiansen and A. de Meijere, Acta Chem. Scand., 1966, 78, 142.
22. H. Günther and D. Wendisch, Angew. Chem., 1966, 78, 266.
23. W. Lüttke and A. de Meijere, Angew. Chem., 1966, 78, 544.
24. M. R. Bendall and D. T. Pegg, J. Magn. Reson., 1983, 53, 272.
25. A. Bax, J. Magn. Reson., 1984, 57, 314.
26. L. J. Lin and G. A. Cordell, J. Chem. Soc., Chem. Commun., 1986, 377.
27. R. E. Hurd and B. K. John, J. Magn. Reson., 1991, 91, 648.
28. H. Kessler, C. Griesinger and K. Wagner, J. Am. Chem. Soc., 1987, 109, 6927.
29. O. Jardetzky, Biochim. Biophys. Acta, 1980, 621, 227.
30. O. Jardetzky and G. C. K. Roberts, NMR in molecular biology, Academic Press, New York, 1981.
31. G. C. K. Roberts and O. Jardetzky, Adv. Protein Chem., 1970, 24, 447.
32. P. Ladam, J. Gharbi-Benarous, M. Pioto, M. Delaforge and J.-P. Girault, Magn. Reson. Chem., 1994, 32, 1.
33. A. De Marco, M. Llinás and K. Wüthrich, Biopolymers, 1978, 17, 637.
34. H. Günther, H. Klose and D. Cremer, Chem. Ber., 1971, 104, 3884.
35. C. A. G. Haasnoot, F. A. A. M. De Leeuw and C. Altona, Tetrahedron, 1980, 36, 2783.
36. I. Tvaroska, M. Hricovini and E. Petrakova, Carbohydr. Res., 1989, 189, 359.
37. H. Günther, NMR Spectroscopy, Wiley, New York, 1994.
38. P. Dauber-Osguthorpe, V. A. Roberts, D. J. Osguthorpe, J. Wolff, M. Genest and A. T. Hagler, Proteins: Struct., Funct. and Genet., 1988, 4, 31.
39. M. Clark, R. D. Cramer and N. Van Opdenbosh, J. Comput. Chem., 1989, 10, 982.
40. K. B. Wiberg, R. F. W. Bader and C. D. H. Lau, J. Am. Chem. Soc., 1987, 109, 1001.
41. A. T. Hagler, S. Lifson and P. Dauber, J. Am. Chem. Soc., 1979, 101, 5122.
42. A. T. Hagler, S. Lifson and P. Dauber, J. Am. Chem. Soc., 1979, 101, 5131.
43. W. J. Hehre, R. F. Stewart and J. A. Pople, J. Chem. Phys., 1971, 51, 2657.
44. W. J. Hehre, R. Ditchfield and J. A. Pople, J. Chem. Phys., 1972, 56, 2257.
45. J. J. Stewart, J. Comp.-Aided Mol. Des., 1990, 4, 1.
46. G. Del Re, J. Am. Chem. Soc., 1958, 4031.
47. H. Berthod and A. Pullman, J. Chem. Phys., 1965, 62, 942.
48. S. K. Burt, D. Mackay and A. T. Nagler, Computer-Aided Drug Design, Marcel Dekker and Basel, New York, 1989.
49. W. F. van Gunsteren and H. J. C. Berendsen, Angew. Chem., Int. Ed. Engl., 1990, 29, 992.
50. H. Kessler, C. Griesinger, J. Lautz, A. Müller, W. F. van Gunsteren and H. J. C. Berendsen, J. Am. Chem. Soc., 1988, 110, 3393.
51. P. H. Hünenberger, A. E. Mark and W. F. van Gunsteren, J. Mol. Biol., 1995, 252, 492.
52. K. Curry, M. J. Peet, D. S. K. Magnuson and H. McLennan, J. Med Chem., 1988, 31, 864.
53. K. Curry, Can. J. Physiol. Pharmacol., 1991, 69, 1076.
54. Z. Q. Gu, D. Hesson, J. C. Pelletier and M. L. Meccechini, J. Med. Chem., 1995, 38, 2518.
55. N. Todeschi, J. Gharbi-Benarous, F. Acher, V. Larue, J. P. Pin, J. Bockaert, R. Azerad and J.-P. Girault, Bioog. Med. Chem., 1997, 5, 335.
56. N. Todeschi, J. Gharbi-Benarous, F. Acher, R. Azerad and J.-P. Girault, J. Chem. Soc., Perkin Trans. 2, 1996, 1337.
57. SYBYL, TRIPOS, St. Louis, MO, 1992.